AQR Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,816
| Closed | -$810K | – | 2908 |
|
|
2024
Q2 | $810K | Buy |
19,816
+71
| +0.4% | +$2.9K | ﹤0.01% | 1846 |
|
|
2024
Q1 | $835K | Buy |
19,745
+167
| +0.9% | +$7.06K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $830K | Buy |
+19,578
| New | +$830K | ﹤0.01% | 1670 |
|
|
2023
Q3 | – | Sell |
-7,021
| Closed | -$223K | – | 2403 |
|
|
2023
Q2 | $223K | Sell |
7,021
-6,630
| -49% | -$211K | ﹤0.01% | 2054 |
|
|
2023
Q1 | $333K | Sell |
13,651
-2,754
| -17% | -$67.2K | ﹤0.01% | 1915 |
|
|
2022
Q4 | $517K | Sell |
16,405
-7,485
| -31% | -$236K | ﹤0.01% | 1803 |
|
|
2022
Q3 | $675K | Buy |
23,890
+1,237
| +5% | +$35K | ﹤0.01% | 1669 |
|
|
2022
Q2 | $599K | Buy |
22,653
+13,363
| +144% | +$353K | ﹤0.01% | 1622 |
|
|
2022
Q1 | $325K | Buy |
+9,290
| New | +$325K | ﹤0.01% | 1946 |
|